Celcuity (CELC) Other Accumulated Expenses (2018 - 2025)
Celcuity (CELC) posted Other Accumulated Expenses of $20.9 million for Q4 2025, up 280.96% on a QoQ basis from $5.5 million in Q4 2024, and up 280.96% year-over-year from $5.5 million in Q4 2024.
Celcuity (CELC) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
Celcuity's Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $20.9 million for Q4 2025.
- Quarterly Other Accumulated Expenses rose 280.96% year-over-year to $20.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.9 million (up 280.96% YoY) and the FY2025 annual result came in at $20.9 million, up 280.96% from the prior year.
- Other Accumulated Expenses was $20.9 million for Q4 2025 at Celcuity, up from $5.5 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $20.9 million in Q4 2025 and bottomed at $5.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.87 Mn |
| Dec 31, 2024 | 5.48 Mn |
| Dec 31, 2019 | 112,746.00 |
| Dec 31, 2018 | 52,347.00 |